Entropy Technologies LP Takes $554,000 Position in Sotera Health Company $SHC

Entropy Technologies LP purchased a new position in Sotera Health Company (NASDAQ:SHC) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 38,652 shares of the company’s stock, valued at approximately $554,000.

A number of other hedge funds also recently bought and sold shares of SHC. IFP Advisors Inc grew its position in Sotera Health by 1,105.6% during the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock valued at $26,000 after purchasing an additional 1,371 shares during the last quarter. Rothschild Investment LLC bought a new stake in Sotera Health during the 4th quarter valued at about $27,000. Root Financial Partners LLC raised its holdings in Sotera Health by 217.5% in the first quarter. Root Financial Partners LLC now owns 2,124 shares of the company’s stock worth $30,000 after buying an additional 1,455 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in Sotera Health by 831.4% in the second quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after buying an additional 2,935 shares during the last quarter. Finally, Eurizon Capital SGR S.p.A. bought a new position in shares of Sotera Health in the fourth quarter worth approximately $40,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

SHC opened at $17.53 on Thursday. The company’s 50-day simple moving average is $16.78 and its two-hundred day simple moving average is $16.36. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82. The stock has a market capitalization of $5.00 billion, a P/E ratio of 42.76 and a beta of 1.76. Sotera Health Company has a 52-week low of $11.00 and a 52-week high of $19.85.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.17 by $0.01. The company had revenue of $280.05 million for the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The firm’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. As a group, analysts predict that Sotera Health Company will post 0.87 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently commented on SHC. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. The Goldman Sachs Group started coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective for the company. Weiss Ratings raised Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Piper Sandler reiterated an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a research note on Wednesday, May 6th. Finally, Barclays lifted their target price on Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Eight research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $20.25.

Insider Activity

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 15.36% of the stock is currently owned by corporate insiders.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.